These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30954655)

  • 1. A mode-of-action ontology model for safety evaluation of chemicals: Outcome of a series of workshops on repeated dose toxicity.
    Desprez B; Birk B; Blaauboer B; Boobis A; Carmichael P; Cronin MTD; Curie R; Daston G; Hubesch B; Jennings P; Klaric M; Kroese D; Mahony C; Ouédraogo G; Piersma A; Richarz AN; Schwarz M; van Benthem J; van de Water B; Vinken M
    Toxicol In Vitro; 2019 Sep; 59():44-50. PubMed ID: 30954655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
    Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
    Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods.
    Leist M; Lidbury BA; Yang C; Hayden PJ; Kelm JM; Ringeissen S; Detroyer A; Meunier JR; Rathman JF; Jackson GR; Stolper G; Hasiwa N
    ALTEX; 2012; 29(4):373-88. PubMed ID: 23138508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards an integrated in vitro strategy for repeated dose toxicity testing.
    Vanhaecke T; Pauwels M; Vinken M; Ceelen L; Rogiers V
    Arch Toxicol; 2011 May; 85(5):365-6. PubMed ID: 21512801
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative analysis of toxicological evaluations for dermal exposure performed under two different EU regulatory frameworks.
    Westerholm E; Schenk L
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):51-8. PubMed ID: 24269627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of QSAR models using artificial neural network analysis for risk assessment of repeated-dose, reproductive, and developmental toxicities of cosmetic ingredients.
    Hisaki T; Aiba Née Kaneko M; Yamaguchi M; Sasa H; Kouzuki H
    J Toxicol Sci; 2015 Apr; 40(2):163-80. PubMed ID: 25786522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A strategy for systemic toxicity assessment based on non-animal approaches: The Cosmetics Europe Long Range Science Strategy programme.
    Desprez B; Dent M; Keller D; Klaric M; Ouédraogo G; Cubberley R; Duplan H; Eilstein J; Ellison C; Grégoire S; Hewitt NJ; Jacques-Jamin C; Lange D; Roe A; Rothe H; Blaauboer BJ; Schepky A; Mahony C
    Toxicol In Vitro; 2018 Aug; 50():137-146. PubMed ID: 29499337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment.
    Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T
    Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SEURAT-1 approach towards animal free human safety assessment.
    Gocht T; Berggren E; Ahr HJ; Cotgreave I; Cronin MT; Daston G; Hardy B; Heinzle E; Hescheler J; Knight DJ; Mahony C; Peschanski M; Schwarz M; Thomas RS; Verfaillie C; White A; Whelan M
    ALTEX; 2015; 32(1):9-24. PubMed ID: 25372315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OSIRIS, a quest for proof of principle for integrated testing strategies of chemicals for four human health endpoints.
    Vermeire T; Aldenberg T; Buist H; Escher S; Mangelsdorf I; Pauné E; Rorije E; Kroese D
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):136-45. PubMed ID: 23385135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safer chemicals using less animals: kick-off of the European ONTOX project.
    Vinken M; Benfenati E; Busquet F; Castell J; Clevert DA; de Kok TM; Dirven H; Fritsche E; Geris L; Gozalbes R; Hartung T; Jennen D; Jover R; Kandarova H; Kramer N; Krul C; Luechtefeld T; Masereeuw R; Roggen E; Schaller S; Vanhaecke T; Yang C; Piersma AH
    Toxicology; 2021 Jun; 458():152846. PubMed ID: 34216698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated testing and intelligent assessment-new challenges under REACH.
    Ahlers J; Stock F; Werschkun B
    Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel strategies for toxicological risk assessments.
    Roy A; Akbarsha MA
    ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
    [No Abstract]   [Full Text] [Related]  

  • 17. Ontology-based semantic mapping of chemical toxicities.
    Wang RL; Edwards S; Ives C
    Toxicology; 2019 Jan; 412():89-100. PubMed ID: 30468866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse outcome pathway-based screening strategies for an animal-free safety assessment of chemicals.
    Landesmann B; Mennecozzi M; Berggren E; Whelan M
    Altern Lab Anim; 2013 Dec; 41(6):461-71. PubMed ID: 24512230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of acute oral toxicity using the No Observed Adverse Effect Level (NOAEL) from the 28 day repeated dose toxicity studies in rats.
    Bulgheroni A; Kinsner-Ovaskainen A; Hoffmann S; Hartung T; Prieto P
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):16-9. PubMed ID: 18977273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.